These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34293641)

  • 1. SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naïve and previously infected individuals.
    Lombardi A; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Bandera A; Gori A
    J Infect Public Health; 2021 Aug; 14(8):1120-1122. PubMed ID: 34293641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robust Antibody Responses to the BNT162b2 mRNA Vaccine Occur Within a Week After the First Dose in Previously Infected Individuals and After the Second Dose in Uninfected Individuals.
    Hirotsu Y; Amemiya K; Sugiura H; Shinohara M; Takatori M; Mochizuki H; Omata M
    Front Immunol; 2021; 12():722766. PubMed ID: 34512649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of healthcare workers with SARS-CoV-2 infection after vaccination with BNT162b2 vaccine.
    Lombardi A; Renisi G; Consonni D; Oggioni M; Bono P; Uceda Renteria S; Piatti A; Pesatori AC; Castaldi S; Muscatello A; Riboldi L; Ceriotti F; Gori A; Bandera A
    BMC Infect Dis; 2022 Jan; 22(1):97. PubMed ID: 35090388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Vicenti I; Basso M; Gatti F; Scaggiante R; Boccuto A; Zago D; Modolo E; Dragoni F; Parisi SG; Zazzi M
    Int J Infect Dis; 2021 Nov; 112():40-44. PubMed ID: 34481967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
    Olariu TR; Ursoniu S; Marincu I; Lupu MA
    Medicina (Kaunas); 2021 Dec; 57(12):. PubMed ID: 34946275
    [No Abstract]   [Full Text] [Related]  

  • 6. Transmission of SARS-CoV-2 variant B.1.1.7 among vaccinated health care workers.
    Ioannou P; Karakonstantis S; Astrinaki E; Saplamidou S; Vitsaxaki E; Hamilos G; Sourvinos G; Kofteridis DP
    Infect Dis (Lond); 2021 Nov; 53(11):876-879. PubMed ID: 34176397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Previous SARS-CoV-2 Infection on Antibody Response to a Single Immunization with the Pfizer BNT162b mRNA Vaccine Among Healthcare Workers in Foggia, Italy.
    Homan T; Fortunato F; Corso G; Lopalco PL; Prato R; Martinelli D
    Infect Dis Ther; 2022 Feb; 11(1):607-615. PubMed ID: 34964938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
    Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
    Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers.
    Sansone E; Sala E; Tiraboschi M; Albini E; Lombardo M; Indelicato A; Rosati C; Boniotti MB; Castelli F; De Palma G
    Med Lav; 2021 Jun; 112(3):250-255. PubMed ID: 34142670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff.
    Urlaub D; Wolfsdorff N; Durak D; Renken F; Watzl C
    Immun Inflamm Dis; 2021 Dec; 9(4):1702-1706. PubMed ID: 34499821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
    Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose BNT162b2 mRNA COVID-19 vaccine significantly boosts neutralizing antibody response in health care workers recovering from asymptomatic or mild natural SARS-CoV-2 infection.
    Vicenti I; Gatti F; Scaggiante R; Boccuto A; Zago D; Basso M; Dragoni F; Zazzi M; Parisi SG
    Int J Infect Dis; 2021 Jul; 108():176-178. PubMed ID: 34022329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia.
    Cucunawangsih C; Wijaya RS; Lugito NPH; Suriapranata I
    Int J Infect Dis; 2021 Dec; 113():15-17. PubMed ID: 34614445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
    BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody titres decline 3-month post-vaccination with BNT162b2.
    Favresse J; Bayart JL; Mullier F; Elsen M; Eucher C; Van Eeckhoudt S; Roy T; Wieers G; Laurent C; Dogné JM; Closset M; Douxfils J
    Emerg Microbes Infect; 2021 Dec; 10(1):1495-1498. PubMed ID: 34232116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer.
    Mueller T
    Clin Chim Acta; 2021 Jul; 518():9-16. PubMed ID: 33741357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech).
    Korth J; Jahn M; Dorsch O; Anastasiou OE; Sorge-Hädicke B; Eisenberger U; Gäckler A; Dittmer U; Witzke O; Wilde B; Dolff S; Kribben A
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33923063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell response after first dose of BNT162b2 SARS-CoV-2 vaccine among healthcare workers with previous infection or cross-reactive immunity.
    Casado JL; Haemmerle J; Vizcarra P; Rodriguez-Dominguez M; Velasco T; Velasco H; Centenera E; Romero-Hernandez B; Fernandez-Escribano M; Vallejo A
    Clin Transl Immunology; 2021; 10(9):e1341. PubMed ID: 34522381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations.
    Efrati S; Catalogna M; Abu Hamad R; Hadanny A; Bar-Chaim A; Benveniste-Levkovitz P; Levtzion-Korach O
    Sci Rep; 2021 Aug; 11(1):16543. PubMed ID: 34400714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis.
    Goupil R; Benlarbi M; Beaubien-Souligny W; Nadeau-Fredette AC; Chatterjee D; Goyette G; Gunaratnam L; Lamarche C; Tom A; Finzi A; Suri RS;
    CMAJ; 2021 May; 193(22):E793-E800. PubMed ID: 33980499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.